DK0759759T3 - P75-TNF-receptorpromotorer - Google Patents

P75-TNF-receptorpromotorer

Info

Publication number
DK0759759T3
DK0759759T3 DK95919786T DK95919786T DK0759759T3 DK 0759759 T3 DK0759759 T3 DK 0759759T3 DK 95919786 T DK95919786 T DK 95919786T DK 95919786 T DK95919786 T DK 95919786T DK 0759759 T3 DK0759759 T3 DK 0759759T3
Authority
DK
Denmark
Prior art keywords
receptorpromotorer
tnf
sequence
upstream
preparation
Prior art date
Application number
DK95919786T
Other languages
Danish (da)
English (en)
Inventor
David Wallach
Inst Of Veterinary Bacte Peter
Gotz Ehrhardt
Oliver Kemper
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Application granted granted Critical
Publication of DK0759759T3 publication Critical patent/DK0759759T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7151—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for tumor necrosis factor [TNF], for lymphotoxin [LT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates
    • C12N2830/85—Vector systems having a special element relevant for transcription from vertebrates mammalian

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Rheumatology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pain & Pain Management (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Developing Agents For Electrophotography (AREA)
DK95919786T 1994-05-11 1995-05-11 P75-TNF-receptorpromotorer DK0759759T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL10963394A IL109633A (en) 1994-05-11 1994-05-11 Tnf receptor promoter
PCT/US1995/005853 WO1995031206A1 (en) 1994-05-11 1995-05-11 P75 tnf receptor promoters

Publications (1)

Publication Number Publication Date
DK0759759T3 true DK0759759T3 (da) 2004-02-02

Family

ID=11066126

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95919786T DK0759759T3 (da) 1994-05-11 1995-05-11 P75-TNF-receptorpromotorer

Country Status (13)

Country Link
EP (1) EP0759759B1 (ja)
JP (1) JP3663211B2 (ja)
AT (1) ATE254173T1 (ja)
AU (1) AU699280B2 (ja)
CA (1) CA2189984C (ja)
CY (1) CY2524B1 (ja)
DE (1) DE69532115T2 (ja)
DK (1) DK0759759T3 (ja)
ES (1) ES2206505T3 (ja)
IL (1) IL109633A (ja)
PT (1) PT759759E (ja)
WO (1) WO1995031206A1 (ja)
ZA (1) ZA953841B (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL114615A0 (en) 1995-07-16 1995-11-27 Yeda Res & Dev Modulators of the function of fas receptors and other proteins
US6287558B1 (en) 1997-08-01 2001-09-11 Biohybrio Technologies Llc Devices containing cells or tissue and an agent that inhibits damage by a host cell molecule
IL132105A0 (en) * 1998-12-24 2001-03-19 Yeda Res & Dev Caspase-8 interacting proteins
US20110104186A1 (en) 2004-06-24 2011-05-05 Nicholas Valiante Small molecule immunopotentiators and assays for their detection
CN103945848B (zh) 2011-11-01 2016-09-07 雷斯韦洛吉克斯公司 被取代的喹唑啉酮的口服即释制剂
WO2014046247A1 (ja) 2012-09-20 2014-03-27 東亞合成株式会社 １型ｔｎｆ受容体と２型ｔｎｆ受容体の存在バランスを調節する合成ペプチド及びその利用

Also Published As

Publication number Publication date
EP0759759A4 (en) 1997-11-26
JPH10500304A (ja) 1998-01-13
IL109633A (en) 2005-05-17
CY2524B1 (en) 2006-02-08
JP3663211B2 (ja) 2005-06-22
IL109633A0 (en) 1994-08-26
EP0759759A1 (en) 1997-03-05
AU699280B2 (en) 1998-11-26
ATE254173T1 (de) 2003-11-15
DE69532115T2 (de) 2004-08-26
WO1995031206A1 (en) 1995-11-23
CA2189984C (en) 2008-03-25
AU2546895A (en) 1995-12-05
DE69532115D1 (de) 2003-12-18
ZA953841B (en) 1996-01-17
CA2189984A1 (en) 1995-11-23
ES2206505T3 (es) 2004-05-16
EP0759759B1 (en) 2003-11-12
PT759759E (pt) 2004-01-30

Similar Documents

Publication Publication Date Title
BG102999A (en) New 2,3-diasubstituted-4-(3h)-quinazolinons
MX9804009A (es) Inhibicion de crecimiento tumoral por oligonucleotidos de antisentido para il-8 y receptor de il-8.
IL125124A0 (en) Dimeric forms of the protein fapalpha and uses thereof
DK0662005T3 (da) Mikropartikelpræparater af biologisk nedbrydelige copolymerer
ITRM920412A0 (it) Eteroprostanoidi, procedimento per la loro preparazione e loro impiegoterapeutico.
EP1007537A4 (en) RECEPTOR PROTEIN DESIGNATED BY 2F1
IS4967A (is) Bindill tengdur æxlisdrepthætti
CY2524B1 (en) P75 tnf receptor promoters
IL106894A0 (en) Dorsal tissue affecting factor and compositions
MY106522A (en) Arylaminocarbonyl compounds.
ZA9610278B (en) Pyridylcarbamates, processes and intermediates for their preparation, and their use.
IL139604A0 (en) Novel peptides
GB2325466A (en) Nucleotide sequence from goat liver
ZA200202823B (en) Self-cleaving RNA sequences and their use for the control of protein synthesis.
FR2718727B1 (fr) Carbure de tungstène non steochiométrique.
MX9804068A (es) Nuevos derivados de quinoxalindiona, su preparacion y empleo en medicamentos.
ITRM950130V0 (it) Bidet con rubinetto disposto frontalmente all'utilizzazione.
FR2715821B1 (fr) Dispositif d'aide à la rééducation fonctionnelle, notamment du rachis.
AU7217891A (en) Therapeutic agents, and intermediates for the synthesis thereof
FR2703251B3 (fr) Compositions pour l'application en thérapeutique humaine, caractérisées par l'association d'un muramyl-peptide à une cytokine .
FR2717390B1 (fr) Compositions thérapeutiques à base de peptides capables d'inhiber la libération de pepsine.
FR2702659B1 (fr) Compositions pour l'application en thérapeutique humaine, caractérisées par l'association d'un muramyl-peptide à une cytokine.
FR2717073B1 (fr) Bac à shampoing pour malades allongés, notamment pour grabataires.
RU95122486A (ru) Средство для лечения тикозных гиперкинезов
ITTV940061A0 (it) "pedana, particolarmente per la pratica della scherma".